• Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

ATKJ:US

Price not available for ATKJ:US

Snapshot for Artec Inc/NV (ATKJ)

Open: - Day's Range: - Volume: 0
Previous Close: 0.0010 52wk Range: 0.0001 - 0.0300 1-Yr Rtn: -

Stock Chart for ATKJ

No chart data available.
  • ATKJ:US 0.0010
  • 1M
  • 1Y
0.0010
Interactive ATKJ Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ATKJ

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. SPX -
Earnings Per Share (ttm) -
Est. EPS -
Est. PEG Ratio -
Market Cap (M USD) 0.00
Shares Outstanding (M) 0.00
30 Day Average Volume 0
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement -
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ATKJ

No data available

Company Profile & Key Executives for ATKJ

Artec, Inc. is seeking to manufacture, distribute, and market TUBERCIN in the United States and Canada. The Company's product strenghtens the immune system to eradicate various types of cancer in patients without any side effects.

Ronald ShinnChairmanGerry G KnightExec VP/Coordinator:Funds
George E Williams JrDirectorCecil ThompsonCoordinator:Bahamas
More Company Profile & Key Executives for ATKJ

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil